On Jan. 2, the U.S. Food and Drug Administration permitted the marketing of the Dermapace System, the first shock wave device intended to treat diabetic foot ulcers.
Originally posted here:
FDA gives marketing approval for first shock wave device to treat diabetic foot ulcers